Clinical Trials Network of Tennessee expands statewide network, providing innovative care for patients and delivering impact across Tennessee
MEMPHIS, Tenn., Dec. 23, 2022 (GLOBE NEWSWIRE) -- The Clinical Trials Network of Tennessee (CTN2) supports innovation in healthcare for the citizens of Tennessee by implementing industry-sponsored research from the University of Tennessee Health Science Center (UTHSC) in 87 current clinical trials across the state.
- MEMPHIS, Tenn., Dec. 23, 2022 (GLOBE NEWSWIRE) -- The Clinical Trials Network of Tennessee (CTN2) supports innovation in healthcare for the citizens of Tennessee by implementing industry-sponsored research from the University of Tennessee Health Science Center (UTHSC) in 87 current clinical trials across the state.
- In fiscal year 2022, CTN2 exceeded its goal of $8 million in contract dollars to report a total of over $9.7 million.
- These partnership sites provide the EDW with over 3.58 million patients across Tennessee, representing over 50% of the state’s population.
- Additionally, CTN2 expects to accrue over $12 million in clinical trial contract value to the University of Tennessee and UTHSC.